You are here: Home » Companies » Results
Business Standard

Drug firm Granules India Q1 consolidated net profit up 8% to Rs 120 cr

Drug firm Granules India on Tuesday reported an 8 per cent rise in its consolidated net profit to Rs 120 crore for the quarter ended June 30, 2021.

Granules India | drug maker | Q1 results

Press Trust of India  |  New Delhi 

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing

Drug firm on Tuesday reported an 8 per cent rise in its consolidated net profit to Rs 120 crore for the quarter ended June 30, 2021.

The company had posted a net profit of Rs 111 crore for the corresponding period of the previous fiscal, said in a BSE filing.

Consolidated revenue from operations of the company stood at Rs 850 crore for the quarter under consideration. It was Rs 736 crore for the same period a year ago, it added.

The board of directors has declared its first interim dividend of 25 paise per equity share of Re 1 each, the filing said.

"The last quarter was full of learnings and challenges both in terms of business and battling the pandemic. The business was temporarily impacted, and actions were taken to get it back on track," Chairman and Managing Director Krishna Prasad Chigurupati said.

Granules India is focusing on making its growth strategy more robust while taking a hard look at its product pipeline which is the company's growth engine, he added.

"While remaining confident of our sustainable growth, efforts will be continued to formalise and follow an orbit changing strategy. I remain confident of our future sustainable growth," Chigurupati said.

Shares of Granules India closed at Rs 364.70 per scrip on BSE, down 3.34 per cent from its previous close.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, July 27 2021. 23:08 IST